Bitcoin (BTC) is currently trading within a vulnerable range, facing pressure from significant unrealized losses, the realization of realized losses, and substantialBitcoin (BTC) is currently trading within a vulnerable range, facing pressure from significant unrealized losses, the realization of realized losses, and substantial

Bitcoin Holds Steady in a Fragile Market Range, Weak but Resilient

2025/12/12 03:30
4 min read
  • Bitcoin faces pressure from unrealized losses, sell-offs, and profit-taking by long-term holders.
  • Market stability depends on liquidity improvements and seller exhaustion in the short term.
  • Options market shows defensive positioning, with traders preparing for near-term volatility events.

Bitcoin (BTC) is currently trading within a vulnerable range, facing pressure from significant unrealized losses, the realization of realized losses, and substantial profit-taking by long-term holders. According to the report from blockchain data provider Glassnode, the market remains stable for now, but there is a lack of strong conviction.

The analysts noted that the predominant cryptocurrency is trading in a structurally vulnerable area, and the above three factors influence its pricing behavior currently.

The demand is enough so that the price is kept above the True Market Mean, which is the cost basis of all non-dormant coins even in the presence of the current sell pressure. This shows that the distribution to the buyers is still absorbing.

Overall, the market structure presents a weak yet steady range and patient demand, albeit with the ongoing sell pressure, according to the analysts.

Moreover, short-term prognosis will rely on whether liquidity will improve and sellers will relax their sales. The potential of the market to reclaim key cost-basis levels and proceed beyond this lengthy, psychologically difficult period will be critical in the long run.

Rising Realized Losses Pose Challenges for Market Recovery

In addition, the analysts noted that according to on-chain signals, as the market keeps staying within this weak and yet confined range, time becomes a negative factor. According to them, investors are finding it more and more difficult to bear unrealized losses, and prospects of realizing them increase.

The more the realized losses, the harder it is to recover. This is reinforced by an increase in the profits of the long-term investors.

The price, however, did momentarily regain an upswing above the True Market Means. In the short run, in case of seller exhaustion, the underlying buying factor might result in a re-test of the $95,000 mark and even the STH-Cost Basis of $102,700.

Also Read: Bitcoin Activity Surges as SpaceX Moves $94 Million Before 2026 IPO

The True Market Mean up until this time is the most probable bottom-formation zone, unless there is a new development of a macro shock, the analyst says.

On-chain indicators are warning signs, and off-chain metrics are indicative of the same, as Glassnode states. More precisely, there is negative flow in ETFs, low liquidity in the spot, and minimal speculative interest in the futures markets.

Source: Glassnode

The spot market is experiencing a decline in demand, and it cannot offer any short-term buy-side. This increases the price vulnerability to macroeconomic events and shocks in volatility.

Bitcoin Spot Volume Signals Defensive Market Positioning

The spot relative volume of Bitcoin is close to the lower limit of its 30-day range, which is a sign of defensive positioning throughout the board. Having fewer liquidity-based flows, volatility becomes difficult to absorb, and prices can show lasting movement.

Source: Glassnode

Additionally, the report says that, across the perpetual markets, funding was close to zero or a bit negative, which shows the continued withdrawing of speculative long positions.

Source: Glassnode

Options market activity, in its turn, was relatively subdued, unlike the spike in short-term implied volatility, with traders having been seeking a bigger move. According to the analysts, options markets are defensively positioned and preparing for a volatility event in the near term.

The analysts noted further that the traders are purchasing volatility and not selling it. The buying of the two wings shows hedging and a quest to find the convexity as opposed to sentimental buying.

Notably, the most significant trigger was that of the US Federal Reserve, which indicated that a transition was about to occur to a low-liquidity, mean-reverting environment.

With the announcement of the rate cut, the gamma sellers would resume buying back, which will cause more rapid implied volatility decay towards the end of the year. 

The trend of least resistance leans towards smaller implied volatility and a smoother surface until the end of December unless there should be a hawkish surprise or a substantial change in direction, the report reveals.

Also Read: a16z Crypto Opens Seoul Office as Asian On-Chain Activity Surges

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$69,075.06
$69,075.06$69,075.06
-0.74%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26